PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

The Industry Financial Outlook: Hazy

Pharma and Snapchat?

Brexit and UK Pharma

Top Story
Pharm Exec's Top 50 Companies
Pharm Exec’s 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
... /Read more/
Advertisement
Watch this brief video to hear how trusted case managers can drive patient adherence and better outcomes using in-home education and tele-health support.
Learn more
Oncology
Cancer's Disruptive Dozen
The World Medical Innovation Forum presents its second list of breakthrough technologies—this time focused on oncology.
... /Read more/
Advertisement
Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST
Free registration
Regulatory
US and EU Regulators Seek to Reduce Pharma Inspections
Sharing un-redacted inspection reports between FDA and EMA may reduce duplicate inspections of facilities, writes Jill Wechsler
... /Read more/
Advertisement
Best Practices for Integrating Biomarkers across the Drug Development Continuum
Live webinar: Wednesday, June 22, 2016 11 am EDT (8 am PST)
Register today
From the Editor
Workplace Design That Delivers
William Looney explores the power of workplace aesthetic on the intangibles of culture, morale—and corporate mission—in a visit to one big Pharma's unique US headquarters
... /Read more/
Calendar
/ June 21–22: Patient Engagement Solutions Summit /
Philadelphia, PA.
/ June 22–23: Global Medical Information and Communications Summit /
Barcelona, Spain.
/ June 23–24: Bio/Pharma Product Forecasting Summit /
Philadelphia, PA.
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
/ September 15–16: Compliance Congress for Specialty Products /
Boston, MA
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
Advertisement
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
On Demand
Learn more
 
 
Advertisement
Strategic considerations for clinical development programs in emerging biopharma companies
On Demand
Learn more
Industry update
//Moncef Slaoui, GSK's Chairman, Vaccines, has announced that he will retire from the company next year.//Innovative Medicines Canada (Ottawa, ON) appointed Elaine Campbell as Interim President.//Contract research organization Chiltern (Wilmington, NC and Slough, UK) promoted Richard Pilnik to Chairman, succeeding Nick Thornton.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com